
---
title: '一批新能源龙头砸出深坑。CXO龙头传来大消息，机构高度关注这些超跌股（附股）'
categories: 
 - 金融
 - 证券时报网
 - 数据
headimg: 'https://data.stcn.com/djsj/202208/W020220804504856249533.png'
author: 证券时报网
comments: false
date: Thu, 04 Aug 2022 13:59:00 GMT
thumbnail: 'https://data.stcn.com/djsj/202208/W020220804504856249533.png'
---

<div>   
<p>“新半军”仍是三季度优势风格？</p><p>今天早盘A股各大指数走势分化。截至上午收盘，上证指数上涨0.15%，创业板指数跌0.2%。行业板块方面，半导体、医药、电力等行业涨幅居前，CXO、有机硅、特高压等概念均大涨逾1%。</p><p>大涨板块多有消息面刺激。国家电网董事长辛保安3日表示，下半年将开工建设新一批特高压工程，总投资超1500亿元，进一步发挥电网投资拉动作用，相关概念股早盘大涨。医药股方面，CXO龙头<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="https://info.stcn.com/dc/stock/?stockcode=SZ002821" code="002821">凯莱英</a>宣布大举回购，引发医药股大涨。锂矿概念方面，昨日锂精矿成交价再度回升。分析人士认为，“新半军”仍是三季度优势风格。</p><p><strong>锂矿价格再次上行</strong></p><p>8月3日，锂价风向标澳大利亚锂矿商Pilbara（皮尔巴拉）发布公告称，8月2日在旗下拍卖平台举行了第八次锂精矿拍卖，最终成交价为6350美元/吨，较7月13日拍卖成交价涨2.6%，较6月23日持平。</p><p>在此消息影响下，今天早盘锂矿概念大涨。截至上午收盘，<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="https://info.stcn.com/dc/stock/?stockcode=SZ002667" code="002667">鞍重股份</a>涨停，<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="https://info.stcn.com/dc/stock/?stockcode=SZ002240" code="002240">盛新锂能</a>、<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="https://info.stcn.com/dc/stock/?stockcode=SS600367" code="600367">红星发展</a>等多只个股大涨逾4%。</p><p>以锂矿为首的新能源板块，近期出现大幅震荡走势，一批龙头大幅反弹后7月份以来又出现较大回调。数据宝粗略统计，5家以上机构评级且市值100亿元以上的个股中，有30多只新能源个股7月高点以来回调超20%。具体来看，<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="https://info.stcn.com/dc/stock/?stockcode=SS600096" code="600096">云天化</a>、<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="https://info.stcn.com/dc/stock/?stockcode=NEEQ835185" code="835185">贝特瑞</a>、<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="https://info.stcn.com/dc/stock/?stockcode=SZ002895" code="002895">川恒股份</a>等10多只个股回调逾25%。</p><p style="text-align:center"><img data-galleryid data-ratio="1.3032015065913372" data-s="300,640" data-type="png" data-w="531" src="https://data.stcn.com/djsj/202208/W020220804504856249533.png" data-imgqrcoded="1" oldsrc="W020220804504856249533.png" referrerpolicy="no-referrer"></p><p><a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="https://info.stcn.com/dc/stock/?stockcode=SS601377" code="601377">兴业证券</a>从交易拥挤度、微观流动性、宏观流动性等5个指标看“新半军”，认为“新半军”仍是三季度优势风格，在7月通过震荡和下沉消化拥挤度压力后，8月、9月可以更乐观点。</p><p><strong>CXO龙头传来大消息</strong></p><p>作为赛道股之一，今年CXO板块表现最差，今年累计跌幅超过21%。<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="https://info.stcn.com/dc/stock/?stockcode=SZ002821" code="002821">凯莱英</a>昨日公布，拟以集中竞价方式（4亿元-8亿元）回购公司股份，回购价不超过290元/股，本次回购A股股份将用于后续实施股权激励及注销减少注册资本。</p><p><a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="https://info.stcn.com/dc/stock/?stockcode=SS600918" code="600918">中泰证券</a>认为，<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="https://info.stcn.com/dc/stock/?stockcode=SZ002821" code="002821">凯莱英</a>本次回购有两方面积极影响：一方面体现了公司对中长期持续、稳健发展的信心，将对市场信心有很好的提振作用；另一方面，回购股份后续将用于实施公司股权激励，将有利于进一步调动团队积极性，将企业、员工、股东利益统一和绑定。</p><p>在此消息影响下，CXO板块大幅上涨，今天上午收盘<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="https://info.stcn.com/dc/stock/?stockcode=SZ002821" code="002821">凯莱英</a>大涨逾6%，<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="https://info.stcn.com/dc/stock/?stockcode=SZ300363" code="300363">博腾股份</a>、<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="https://info.stcn.com/dc/stock/?stockcode=SS688202" code="688202">美迪西</a>等多只个股涨逾4%。</p><p>从技术形态来看，CXO板块属于低位反弹的情况。个股也是跌多涨少，<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="https://info.stcn.com/dc/stock/?stockcode=SZ301201" code="301201">诚达药业</a>、<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="https://info.stcn.com/dc/stock/?stockcode=SZ002821" code="002821">凯莱英</a>、<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="https://info.stcn.com/dc/stock/?stockcode=SZ000739" code="000739">普洛药业</a>、<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="https://info.stcn.com/dc/stock/?stockcode=SZ300702" code="300702">天宇股份</a>等个股年内跌幅超过40%。CXO板块A股市值蒸发超过2900亿元，<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="https://info.stcn.com/dc/stock/?stockcode=SS603259" code="603259">药明康德</a>、<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="https://info.stcn.com/dc/stock/?stockcode=SZ002821" code="002821">凯莱英</a>两只个股市值蒸发超过500亿元，<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="https://info.stcn.com/dc/stock/?stockcode=SS603707" code="603707">健友股份</a>、<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="https://info.stcn.com/dc/stock/?stockcode=SZ300347" code="300347">泰格医药</a>、<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="https://info.stcn.com/dc/stock/?stockcode=SZ000739" code="000739">普洛药业</a>等个股市值蒸发逾200亿元。</p><p>民生证券认为CXO板块头部公司中报业绩展现高成长性，且在手订单充足未来仍具有持续高速增长的确定性，随着CXO企业中报陆续披露，CXO板块成长性将进一步得到验证。根据机构一致预测，<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="https://info.stcn.com/dc/stock/?stockcode=SS603259" code="603259">药明康德</a>明年净利增速接近17%，2024年净利增速为28%；<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="https://info.stcn.com/dc/stock/?stockcode=SZ300759" code="300759">康龙化成</a>未来两年净利增速均值均超过30%。</p><p>随着股价的持续回调，部分个股机构一致预测上涨空间更高了。具体来看，7家机构一致预测<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="https://info.stcn.com/dc/stock/?stockcode=SZ301047" code="301047">义翘神州</a>（6家券商没有目标价，安信证券给予360元目标价，复权后目标价256元）上涨空间超128%。此外，<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="https://info.stcn.com/dc/stock/?stockcode=SZ300363" code="300363">博腾股份</a>、<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="https://info.stcn.com/dc/stock/?stockcode=SZ002821" code="002821">凯莱英</a>、<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="https://info.stcn.com/dc/stock/?stockcode=SS603538" code="603538">美诺华</a>、<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="https://info.stcn.com/dc/stock/?stockcode=SZ300702" code="300702">天宇股份</a>等个股机构一致预测上涨空间均超60%。(数据宝 陈见南）</p><p style="text-align: center;"><img data-galleryid data-ratio="0.842911877394636" data-s="300,640" data-type="png" data-w="522" src="https://data.stcn.com/djsj/202208/W020220804504856688650.png" data-imgqrcoded="1" oldsrc="W020220804504856688650.png" referrerpolicy="no-referrer"></p>
  
</div>
            